Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation

J Font de Mora1, A Porras, N Ahn

  • 1Laboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Insights

Mitogen-activated protein kinase (MAPK) activation by insulin does not drive adipocyte differentiation and may inhibit it. Blocking MAPK with PD98059 enhanced differentiation and reversed inhibition by TNF-alpha.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Ras proteins are key mediators of insulin signaling in 3T3-L1 fibroblasts, influencing adipocyte differentiation and kinase activation.
  • Mitogen-activated protein kinase (MAPK) is activated by insulin and Ras, but its role in adipogenesis is unclear.

Purpose of the Study:

  • To investigate the role of MAPK activation in insulin-induced adipocyte differentiation.
  • To determine if MAPK activation is necessary for or antagonistic to adipogenesis.

Main Methods:

  • Utilized MEK-specific inhibitor PD98059 to block MAPK activation in 3T3-L1 preadipocytes.
  • Examined the effects of PD98059 on insulin- and Ras-induced differentiation.
  • Investigated the impact of TNF-alpha on MAPK activation and adipogenesis, and the effect of PD98059.
  • Analyzed differentiation in 3T3-L1 cells with hyperactivated MEK1 or overexpressed MAPK.

Main Results:

  • PD98059 inhibited insulin- and Ras-induced MAPK activation without impairing adipocytic differentiation, and sometimes enhanced it.
  • Tumor necrosis factor alpha (TNF-alpha) activated MAPK and inhibited adipogenesis; PD98059 blocked TNF-alpha-induced MAPK activation and reversed low-dose TNF-alpha-mediated inhibition.
  • Hyperactivation or overexpression of MEK1 or MAPK impaired adipocytic differentiation, an effect reversed by PD98059.

Conclusions:

  • MAPK activation is not required for insulin-induced adipocyte differentiation and actively antagonizes the process.
  • Inhibiting MAPK signaling can enhance adipogenesis and overcome inhibitory signals like TNF-alpha.
  • MAPK pathway plays an inhibitory role in 3T3-L1 adipocytic differentiation.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...